Home › Chronic Inflammatory Demyelinating Polyradiculoneuropathy › Maryland
Chronic Inflammatory Demyelinating Polyradiculoneuropathy clinical trials in Maryland
3 studies for Chronic Inflammatory Demyelinating Polyradiculoneuropathy are looking for participants at sites in Maryland.
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Johns Hopkins Hospital, Baltimore
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT05327114A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
- Erlanger Health System, Columbia
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06920004A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Johns Hopkins Hospital- Site Number : 8400015, Baltimore
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06290141From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.